Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE2
UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Lonquek for Autologous Stem Cell Mobilization
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
NMP in Relapsed / Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy
- Status
- UNKNOWN
- Phase
- PHASE1
Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance
- Status
- COMPLETED
- Phase
- PHASE2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1